Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.

Mangialasche F, Westman E, Kivipelto M, Muehlboeck JS, Cecchetti R, Baglioni M, Tarducci R, Gobbi G, Floridi P, Soininen H, Kłoszewska I, Tsolaki M, Vellas B, Spenger C, Lovestone S, Wahlund LO, Simmons A, Mecocci P; AddNeuroMed consortium..

J Intern Med. 2013 Jun;273(6):602-21. doi: 10.1111/joim.12037. Epub 2013 Feb 28.

2.

Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.

Mangialasche F, Solomon A, Kåreholt I, Hooshmand B, Cecchetti R, Fratiglioni L, Soininen H, Laatikainen T, Mecocci P, Kivipelto M.

Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.

PMID:
24113154
3.

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.

Westman E, Muehlboeck JS, Simmons A.

Neuroimage. 2012 Aug 1;62(1):229-38. doi: 10.1016/j.neuroimage.2012.04.056. Epub 2012 May 3.

PMID:
22580170
4.

Tocopherols and tocotrienols plasma levels are associated with cognitive impairment.

Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, Cecchetti R, Baglioni M, Simmons A, Soininen H, Tsolaki M, Kloszewska I, Vellas B, Lovestone S, Mecocci P; AddNeuroMed Consortium..

Neurobiol Aging. 2012 Oct;33(10):2282-90. doi: 10.1016/j.neurobiolaging.2011.11.019. Epub 2011 Dec 20.

PMID:
22192241
5.

AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.

Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium.; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2011 Oct 1;58(3):818-28. doi: 10.1016/j.neuroimage.2011.06.065. Epub 2011 Jul 1.

PMID:
21763442
6.

An MRI-based index to measure the severity of Alzheimer's disease-like structural pattern in subjects with mild cognitive impairment.

Spulber G, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Wahlund LO, Westman E; dNeuroMed consortium and for the Alzheimer Disease Neuroimaging Initiative..

J Intern Med. 2013 Apr;273(4):396-409. doi: 10.1111/joim.12028. Epub 2013 Jan 30.

7.

Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.

Westman E, Simmons A, Zhang Y, Muehlboeck JS, Tunnard C, Liu Y, Collins L, Evans A, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium..

Neuroimage. 2011 Jan 15;54(2):1178-87. doi: 10.1016/j.neuroimage.2010.08.044. Epub 2010 Aug 25.

PMID:
20800095
8.

MRI and CSF studies in the early diagnosis of Alzheimer's disease.

de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.

J Intern Med. 2004 Sep;256(3):205-23.

9.

Regional magnetic resonance imaging measures for multivariate analysis in Alzheimer's disease and mild cognitive impairment.

Westman E, Aguilar C, Muehlboeck JS, Simmons A.

Brain Topogr. 2013 Jan;26(1):9-23. doi: 10.1007/s10548-012-0246-x. Epub 2012 Aug 14.

10.

High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.

Mangialasche F, Kivipelto M, Mecocci P, Rizzuto D, Palmer K, Winblad B, Fratiglioni L.

J Alzheimers Dis. 2010;20(4):1029-37. doi: 10.3233/JAD-2010-091450.

PMID:
20413888
11.

Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.

Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO; AddNeuroMed consortium..

PLoS One. 2011;6(7):e22506. doi: 10.1371/journal.pone.0022506. Epub 2011 Jul 21.

12.

Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairment.

Aguilar C, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Spenger C, Simmons A, Wahlund LO.

Psychiatry Res. 2013 May 30;212(2):89-98. doi: 10.1016/j.pscychresns.2012.11.005. Epub 2013 Mar 29.

PMID:
23541334
13.

Application of a MRI based index to longitudinal atrophy change in Alzheimer disease, mild cognitive impairment and healthy older individuals in the AddNeuroMed cohort.

Aguilar C, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Wahlund LO, Simmons A, Westman E; AddNeuroMed Consortium..

Front Aging Neurosci. 2014 Jul 14;6:145. doi: 10.3389/fnagi.2014.00145. eCollection 2014.

14.

Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed study.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium..

Neurobiol Aging. 2011 Jul;32(7):1198-206. doi: 10.1016/j.neurobiolaging.2009.07.008. Epub 2009 Aug 14.

PMID:
19683363
15.

Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease.

Liu Y, Paajanen T, Zhang Y, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H; AddNeuroMed Consortium..

Neurobiol Aging. 2010 Aug;31(8):1375-85. doi: 10.1016/j.neurobiolaging.2010.01.022. Epub 2010 May 5.

PMID:
20447732
16.

Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progression.

Furney SJ, Kronenberg D, Simmons A, Güntert A, Dobson RJ, Proitsi P, Wahlund LO, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Spenger C, Lovestone S.

J Alzheimers Dis. 2011;26 Suppl 3:395-405. doi: 10.3233/JAD-2011-0044.

PMID:
21971479
17.

Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.

Lebedev AV, Westman E, Van Westen GJ, Kramberger MG, Lundervold A, Aarsland D, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Simmons A; Alzheimer's Disease Neuroimaging Initiative and the AddNeuroMed consortium..

Neuroimage Clin. 2014 Aug 28;6:115-25. doi: 10.1016/j.nicl.2014.08.023. eCollection 2014.

18.

Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.

Plant C, Teipel SJ, Oswald A, Böhm C, Meindl T, Mourao-Miranda J, Bokde AW, Hampel H, Ewers M.

Neuroimage. 2010 Mar;50(1):162-74. doi: 10.1016/j.neuroimage.2009.11.046. Epub 2009 Dec 2.

19.

Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.

Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RL, Neto MR.

Int Psychogeriatr. 2002 Mar;14(1):59-72.

PMID:
12094908
20.

The Effect of Age Correction on Multivariate Classification in Alzheimer's Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects.

Falahati F, Ferreira D, Soininen H, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Lovestone S, Eriksdotter M, Wahlund LO, Simmons A, Westman E; AddNeuroMed consortium and the Alzheimer’s Disease Neuroimaging Initiative..

Brain Topogr. 2016 Mar;29(2):296-307. doi: 10.1007/s10548-015-0455-1. Epub 2015 Oct 6.

Supplemental Content

Support Center